548-03-8 Usage
Uses
Used in Pharmaceutical Development:
Protohypericin is utilized as a precursor compound for the synthesis of hypericin, which possesses medicinal properties. Its role in the development of new pharmaceuticals is significant due to its potential to contribute to the treatment of various diseases.
Used in Anticancer Applications:
In the field of oncology, protohypericin is employed as a potential anticancer agent. Its antioxidant properties and the ability to target cancer cells make it a candidate for further research and development in cancer treatment.
Used in Antiviral Applications:
Given its potential to combat viral infections, protohypericin is used as an antiviral agent, exploring its capacity to inhibit or reduce the impact of viral diseases.
Used in Anti-inflammatory Applications:
Recognizing its potential anti-inflammatory effects, protohypericin is used as an agent to reduce inflammation, which can be beneficial in treating conditions characterized by inflammatory responses.
Used in Antidepressant Applications:
With demonstrated potential as an anti-depressant, protohypericin is used in the development of treatments for mood disorders, aiming to alleviate symptoms associated with depression.
Used in Natural Medicine:
In the context of natural medicine, protohypericin is used for its broad range of biological activities, offering a holistic approach to health and wellness by leveraging the natural properties of St. John's wort.
Check Digit Verification of cas no
The CAS Registry Mumber 548-03-8 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,4 and 8 respectively; the second part has 2 digits, 0 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 548-03:
(5*5)+(4*4)+(3*8)+(2*0)+(1*3)=68
68 % 10 = 8
So 548-03-8 is a valid CAS Registry Number.
InChI:InChI=1/C30H18O8/c1-9-3-11-19(13(31)5-9)29(37)25-17(35)7-15(33)23-24-16(34)8-18(36)26-28(24)22(21(11)27(23)25)12-4-10(2)6-14(32)20(12)30(26)38/h3-8,31-36H,1-2H3
548-03-8Relevant academic research and scientific papers
Concerning the absorption and photochemical properties of an ω-4-dimethylaminobenzal hypericin derivative
Obermueller,Falk
, p. 1519 - 1526 (2007/10/03)
A hypericin derivative containing ω,ω′ -4-dimethylaminobenzal residues was shown to undergo an intramolecular [2 + 2] cycloaddition upon irradiation leading to a cyclobutane derivative whose main absorption band is hardly shifted as compared to hypericin. The corresponding ω-substituted derivative displayed a 34 nm bathochromic shift and a strongly reduced fluorescence quantum yield rendering it a nice candidate for a photodynamic therapy agent. Unfortunately, however, it produced virtually no photosensitized active oxygen species, making it thus unsuited for this purpose.
